acetazolamide has been researched along with Vascular Calcification in 2 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Vascular Calcification: Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vascular calcification is a recognised source of morbidity among mid-age and elderly subjects." | 5.51 | Would acetazolamide inhibit progression of atheromatous vascular calcification? ( Cochran, M, 2019) |
| "Acetazolamide (ACM) treatment partially reversed the growth deficit of kl/kl mice." | 5.43 | Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice. ( Alesutan, I; Castor, T; Kohlhofer, U; Kübler, L; Kuro-o, M; Lang, F; Leibrock, CB; Mannheim, JG; Michael, D; Pichler, BJ; Quintanilla-Martinez, L; Rosenblatt, KP; Voelkl, J, 2016) |
| "Vascular calcification is a recognised source of morbidity among mid-age and elderly subjects." | 1.51 | Would acetazolamide inhibit progression of atheromatous vascular calcification? ( Cochran, M, 2019) |
| "Acetazolamide (ACM) treatment partially reversed the growth deficit of kl/kl mice." | 1.43 | Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice. ( Alesutan, I; Castor, T; Kohlhofer, U; Kübler, L; Kuro-o, M; Lang, F; Leibrock, CB; Mannheim, JG; Michael, D; Pichler, BJ; Quintanilla-Martinez, L; Rosenblatt, KP; Voelkl, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cochran, M | 1 |
| Leibrock, CB | 1 |
| Alesutan, I | 1 |
| Voelkl, J | 1 |
| Michael, D | 1 |
| Castor, T | 1 |
| Kohlhofer, U | 1 |
| Quintanilla-Martinez, L | 1 |
| Kübler, L | 1 |
| Mannheim, JG | 1 |
| Pichler, BJ | 1 |
| Rosenblatt, KP | 1 |
| Kuro-o, M | 1 |
| Lang, F | 1 |
2 other studies available for acetazolamide and Vascular Calcification
| Article | Year |
|---|---|
Would acetazolamide inhibit progression of atheromatous vascular calcification?
Topics: Acetazolamide; Acidosis; Aged; Alkaline Phosphatase; Calcium; Disease Progression; Humans; Hydrogen- | 2019 |
Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice.
Topics: Acetazolamide; Acidosis; Aging; Alkaline Phosphatase; Animals; Calcitriol; Calcium; Carbonic Anhydra | 2016 |